Compare HITI & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HITI | OSUR |
|---|---|---|
| Founded | 2009 | 2000 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 213.6M | 214.1M |
| IPO Year | 2021 | 2000 |
| Metric | HITI | OSUR |
|---|---|---|
| Price | $2.48 | $3.21 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | ★ $6.13 | $3.00 |
| AVG Volume (30 Days) | ★ 371.2K | 364.2K |
| Earning Date | 03-17-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $167,064,000.00 |
| Revenue This Year | $23.73 | $4.48 |
| Revenue Next Year | $12.80 | $7.76 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.10 | $2.08 |
| 52 Week High | $4.06 | $3.76 |
| Indicator | HITI | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 59.64 | 57.93 |
| Support Level | $2.43 | $3.10 |
| Resistance Level | $2.51 | $3.25 |
| Average True Range (ATR) | 0.08 | 0.12 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 91.06 | 84.26 |
High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, and others. The company's reportable operating segments are: Bricks and mortar, which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada, followed by the United States of America, and other international markets.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.